p erk1 2 alphalisa sure fire ultra assay kit (Revvity)
Structured Review
P Erk1 2 Alphalisa Sure Fire Ultra Assay Kit, supplied by Revvity, used in various techniques. Bioz Stars score: 91/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alphalisa+surefire+ultra+kits/AlphaLISA+SureFire+Ultra+p-ERK1%2F2+(Thr202%2FTyr204)+Assay+Kit+-+High+Volume/pmc10386454-110-24-29
Average 91 stars, based on 20 article reviews
Images
Related Articles
Multiple Displacement Amplification:Article Title: Selective Inhibitors of mTORC1 Activate 4EBP1 and Suppress Tumor Growth Article Snippet: Cells were obtained from ATCC, grown in appropriate medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin, and maintained at 37°C in a humidified incubator at 5% CO 2 . .. mTOR substrate phosphorylation in MDA-MB-468 and MCF-7 cells was assayed using Article Title: Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth. Article Snippet: 1Department of Biology, Revolution Medicines, Inc., Redwood City, CA, USA.. 2Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.. 3Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA. .. 1Department of Biology, Revolution Medicines, Inc., Redwood City, CA, USA.. 2Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan-Kettering Cancer Center, Article Title: Selective Inhibitors of mTORC1 Activate 4EBP1 and Suppress Tumor Growth Article Snippet: Cell culture and reagents Cells were obtained from ATCC, grown in appropriate medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin, and maintained at 37°C in a humidified incubator at 5% CO 2 . .. AlphaLISA and MSD analysis of 4EBP1, S6K, and AKT phosphorylation mTOR substrate phosphorylation in MDA-MB-468 and MCF-7 cells was assayed using Phospho-proteomics:Article Title: Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth. Article Snippet: 1Department of Biology, Revolution Medicines, Inc., Redwood City, CA, USA.. 2Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.. 3Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA. .. 1Department of Biology, Revolution Medicines, Inc., Redwood City, CA, USA.. 2Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.. 3Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA. .. Article Title: Supraphysiological levels of GDF 11 induce striated muscle atrophy Article Snippet: .. Cells were lysed using Phosphosafe Buffer (VWR EM71296‐4) for 45 min, and phosphorylation of SMAD2/3 or SMAD1/5/8 was determined using Article Title: Microgel encapsulated nanoparticles for glucose-responsive insulin delivery. Article Snippet: An insulin delivery system that self-regulates blood glucose levels has the potential to limit hypoglycemic events and improve glycemic control.. Glucose-responsive insulin delivery systems have been developed by coupling glucose oxidase with a stimuli-responsive biomaterial.. However, the challenge of achieving desirable release kinetics (i.e., insulin release within minutes after glucose elevation and duration of release on the order of weeks) still remains. Enzyme-linked Immunosorbent Assay:Article Title: Microgel encapsulated nanoparticles for glucose-responsive insulin delivery. Article Snippet: An insulin delivery system that self-regulates blood glucose levels has the potential to limit hypoglycemic events and improve glycemic control.. Glucose-responsive insulin delivery systems have been developed by coupling glucose oxidase with a stimuli-responsive biomaterial.. However, the challenge of achieving desirable release kinetics (i.e., insulin release within minutes after glucose elevation and duration of release on the order of weeks) still remains. |

